BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765-773. [PMID: 19183150 DOI: 10.1111/j.1365-2036.2009.03937.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 158] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients 2021;13:575. [PMID: 33572262 DOI: 10.3390/nu13020575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146-156. [PMID: 20125092 DOI: 10.1038/nrgastro.2010.5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
3 Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:142-9. [PMID: 23318268 DOI: 10.1038/nrgastro.2012.255] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
4 Pike BL, Paden KA, Alcala AN, Jaep KM, Gormley RP, Maue AC, Christmann BS, Elson CO, Riddle MS, Porter CK. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome. J Travel Med 2015;22:242-50. [PMID: 26058758 DOI: 10.1111/jtm.12218] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
5 Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
6 Fan K, Talley NJ. Functional dyspepsia and duodenal eosinophilia: A new model: Dyspepsia and duodenal eosinophilia. Journal of Digestive Diseases 2017;18:667-77. [DOI: 10.1111/1751-2980.12556] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
7 Shea-Donohue T, Stiltz J, Zhao A, Notari L. Mast cells. Curr Gastroenterol Rep. 2010;12:349-357. [PMID: 20711694 DOI: 10.1007/s11894-010-0132-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
8 Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, Falk GW, Murray JA, Gehman LT, Chang AT, Singh B, Rasmussen HS, Genta RM. Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00592-9. [PMID: 34089846 DOI: 10.1016/j.cgh.2021.05.053] [Reference Citation Analysis]
9 Jung HK, Talley NJ. Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift. J Neurogastroenterol Motil. 2018;24:345-354. [PMID: 29791992 DOI: 10.5056/jnm18060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
10 Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front Cell Infect Microbiol 2020;10:468. [PMID: 33014892 DOI: 10.3389/fcimb.2020.00468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
11 Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2019;31:e13718. [PMID: 31498961 DOI: 10.1111/nmo.13718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
12 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
13 Lee EH, Yang HR, Lee HS. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2016;22:459-69. [PMID: 27053514 DOI: 10.5056/jnm15174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
14 Crişan IM, Dumitraşcu DL. Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications. Clujul Med 2014;87:73-9. [PMID: 26528001 DOI: 10.15386/cjmed-269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 Nocerino R, Di Costanzo M, Bedogni G, Cosenza L, Maddalena Y, Di Scala C, Della Gatta G, Carucci L, Voto L, Coppola S, Iannicelli AM, Berni Canani R. Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow's Milk Allergy. The Journal of Pediatrics 2019;213:137-142.e2. [DOI: 10.1016/j.jpeds.2019.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Walker MM, Aggarwal KR, Shim LS, Bassan M, Kalantar JS, Weltman MD, Jones M, Powell N, Talley NJ. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. J Gastroenterol Hepatol. 2014;29:474-479. [PMID: 24304041 DOI: 10.1111/jgh.12419] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 13.7] [Reference Citation Analysis]
17 Nasser Y, Boeckxstaens GE, Wouters MM, Schemann M, Vanner S. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:455-469. [PMID: 24602069 DOI: 10.1111/nmo.12316] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
18 Zanini B, Lanzarotto F, Villanacci V, Carabellese N, Ricci C, Lanzini A. Clinical expression of lymphocytic duodenosis in “mild enteropathy” celiac disease and in functional gastrointestinal syndromes. Scandinavian Journal of Gastroenterology 2014;49:794-800. [DOI: 10.3109/00365521.2014.919017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
19 Wang X, Li X, Ge W, Huang J, Li G, Cong Y, Li F, Liu Z, Liu Z, Li Y, Yuan H. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia. Ann Diagn Pathol. 2015;19:50-56. [PMID: 25735567 DOI: 10.1016/j.anndiagpath.2015.02.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
20 Kiss Z, Tél B, Farkas N, Garami A, Vincze Á, Bajor J, Sarlós P, Márta K, Erős A, Mikó A, Szakács Z, Pécsi D, Mátrai P, Hegyi P, Veres G. Eosinophil Counts in the Small Intestine and Colon of Children Without Apparent Gastrointestinal Disease: A Meta-analysis. J Pediatr Gastroenterol Nutr 2018;67:6-12. [PMID: 29394213 DOI: 10.1097/MPG.0000000000001904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Lee H, Chung H, Park JC, Shin SK, lee SK, Lee YC. Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain. Neurogastroenterol Motil 2014;26:786-93. [DOI: 10.1111/nmo.12325] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
22 Giancola F, Volta U, Repossi R, Latorre R, Beeckmans D, Carbone F, Van den Houte K, Bianco F, Bonora E, Gori A, Costanzini A, Boschetti E, Caio G, Vanuytsel T, Stanghellini V, Tack J, De Giorgio R. Mast cell-nerve interactions correlate with bloating and abdominal pain severity in patients with non-celiac gluten / wheat sensitivity. Neurogastroenterol Motil 2020;32:e13814. [PMID: 32022388 DOI: 10.1111/nmo.13814] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
23 Cirillo C, Bessissow T, Desmet A, Vanheel H, Tack J, Vanden Berghe P. Evidence for Neuronal and Structural Changes in Submucous Ganglia of Patients With Functional Dyspepsia. American Journal of Gastroenterology 2015;110:1205-15. [DOI: 10.1038/ajg.2015.158] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 13.5] [Reference Citation Analysis]
24 Park SW, Lee H, Lee HJ, Chung H, Park JC, Shin SK, Lee SK, Lee YC. Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain. Dis Esophagus 2015;28:512-9. [PMID: 24766344 DOI: 10.1111/dote.12231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
25 Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, Mccallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13192. [DOI: 10.1111/nmo.13192] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
26 González-castro AM, Martínez C, Salvo-romero E, Fortea M, Pardo-camacho C, Pérez-berezo T, Alonso-cotoner C, Santos J, Vicario M. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome: Mucosal dysfunction in irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2017;32:53-63. [DOI: 10.1111/jgh.13417] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
27 Walker MM, Potter MD, Talley NJ. Eosinophilic colitis and colonic eosinophilia. Curr Opin Gastroenterol 2019;35:42-50. [PMID: 30480590 DOI: 10.1097/MOG.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013;62:1160-1168. [PMID: 22637702 DOI: 10.1136/gutjnl-2012-302093] [Cited by in Crossref: 156] [Cited by in F6Publishing: 158] [Article Influence: 17.3] [Reference Citation Analysis]
29 Tsai J, Wang I, Shen T, Lin C, Wei C. A 8-year population-based cohort study of irritable bowel syndrome in childhood with history of atopic dermatitis. J Investig Med 2018;66:755-61. [DOI: 10.1136/jim-2017-000631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut 2020;69:591-600. [DOI: 10.1136/gutjnl-2019-318536] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 18.5] [Reference Citation Analysis]
31 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 11.9] [Reference Citation Analysis]
32 Ronkainen J, Aro P, Walker MM, Agréus L, Johansson S, Jones M, Talley NJ. Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2019;50:24-32. [DOI: 10.1111/apt.15308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
33 Carroccio A, Giannone G, Mansueto P, Soresi M, La Blasca F, Fayer F, Iacobucci R, Porcasi R, Catalano T, Geraci G, Arini A, D'Alcamo A, Villanacci V, Florena AM. Duodenal and Rectal Mucosa Inflammation in Patients With Non-celiac Wheat Sensitivity. Clin Gastroenterol Hepatol 2019;17:682-690.e3. [PMID: 30138736 DOI: 10.1016/j.cgh.2018.08.043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
34 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 12.1] [Reference Citation Analysis]
35 Kumari MV, Amarasiri L, Rajindrajith S, Devanarayana NM. Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology? Expert Rev Gastroenterol Hepatol 2021;15:9-24. [PMID: 32909837 DOI: 10.1080/17474124.2020.1821652] [Reference Citation Analysis]
36 Du L, Shen J, Kim JJ, Yu Y, Ma L, Dai N. Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study. Sci Rep 2016;6:34305. [PMID: 27708358 DOI: 10.1038/srep34305] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
37 Talley NJ. Functional dyspepsia and the Rome criteria: a success story. Neurogastroenterol Motil 2015;27:1052-6. [PMID: 26220646 DOI: 10.1111/nmo.12641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
38 Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1:36-42. [PMID: 22053295 DOI: 10.5415/apallergy.2011.1.1.36] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
39 Lee HS, Kim DK, Kim YB, Lee KJ. Effect of acute stress on immune cell counts and the expression of tight junction proteins in the duodenal mucosa of rats. Gut Liver 2013;7:190-6. [PMID: 23560155 DOI: 10.5009/gnl.2013.7.2.190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
40 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
41 Wang XJ, Carlson P, Chedid V, Maselli DB, Taylor AL, McKinzie S, Camilleri M. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol 2021;12:e00329. [PMID: 33843785 DOI: 10.14309/ctg.0000000000000329] [Reference Citation Analysis]
42 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
43 Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1:36-42. [PMID: 22053295 DOI: 10.5415/apallergy.2011.1.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Popa SL, Chiarioni G, David L, Dumitrascu DL. The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia. Am J Ther. 2019;26:e704-e713. [PMID: 31425161 DOI: 10.1097/mjt.0000000000001033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
45 Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol. 2012;107:440-447. [PMID: 22233694 DOI: 10.1038/ajg.2011.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
46 Holtmann GJ, Talley NJ. Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? Gut 2018;67:1911-5. [PMID: 29921653 DOI: 10.1136/gutjnl-2017-314775] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
47 Zacharakis G, Al-Ghamdi S, AlZahrani J, Almasoud A, Arahmane O, AlShehri A, Alharbi MH, Alsalmi MM, Alotibi SB, Algaradi YA, Alsadiq FN, Nikolaidis P. Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice. Korean J Gastroenterol 2020;76:304-13. [PMID: 33361706 DOI: 10.4166/kjg.2020.110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Koloski N, Jones M, Walker MM, Veysey M, Zala A, Keely S, Holtmann G, Talley NJ. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther 2019;49:546-55. [PMID: 30687959 DOI: 10.1111/apt.15120] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
49 Masnadi-Shirazi K, Mirinezhad SK, Salehi S, Halimi M, Vahedi L, Mir Najd Gerami S. Comparison of CD4+ and CD8+ T- lymphocyte in Helicobacter pylori-negative functional dyspepsia. Caspian J Intern Med 2020;11:150-4. [PMID: 32509242 DOI: 10.22088/cjim.11.2.150] [Reference Citation Analysis]
50 Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract--a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014;8:289-99. [PMID: 24450399 DOI: 10.1586/17474124.2014.881716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
51 Chang JY, Talley NJ. An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol. 2011;27:72-78. [PMID: 21099429 DOI: 10.1097/mog.0b013e3283414065] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
52 Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol 2014; 20(14): 3976-3985 [PMID: 24744587 DOI: 10.3748/wjg.v20.i14.3976] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
53 Akhavein M A, Patel NR, Muniyappa PK, Glover SC. Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract 2012;2012:950582. [PMID: 22577375 DOI: 10.1155/2012/950582] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
54 Ishigami H, Matsumura T, Kasamatsu S, Hamanaka S, Taida T, Okimoto K, Saito K, Minemura S, Maruoka D, Nakagawa T, Katsuno T, Fujie M, Arai M. Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clin Transl Gastroenterol. 2017;8:e83. [PMID: 28383567 DOI: 10.1038/ctg.2017.12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
55 Schaeffer DF, Kirsch R, Riddell RH. Mast cells and intestinal motility disorders (mastocytic enteritis/colitis). Dig Dis Sci 2012;57:1118-21. [PMID: 22466075 DOI: 10.1007/s10620-012-2123-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Oustamanolakis P, Tack J. Dyspepsia: organic versus functional. J Clin Gastroenterol. 2012;46:175-190. [PMID: 22327302 DOI: 10.1097/mcg.0b013e318241b335] [Cited by in Crossref: 61] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
57 Ivashkin VT, Zolnikova OY. Irritable Bowel Syndrome in Terms of Changes in the Microbiota. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;29:84-92. [DOI: 10.22416/1382-4376-2019-29-1-84-92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Allen JI, Katzka D, Robert M, Leontiadis GI. American Gastroenterological Association Institute Technical Review on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. Gastroenterology 2015;149:1088-118. [DOI: 10.1053/j.gastro.2015.07.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
59 Lee EH, Yang HR, Lee HS. Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain Disorders. J Neurogastroenterol Motil 2018;24:614-27. [PMID: 30180307 DOI: 10.5056/jnm18050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lied GA. Indication of Immune Activation in Patients with Perceived Food Hypersensitivity. Dig Dis Sci 2014;59:259-66. [DOI: 10.1007/s10620-013-2926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Sabatino G, Maurer CA, Cathomas G, Salerni B. Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther. 2011;34:92-99. [PMID: 21539589 DOI: 10.1111/j.1365-2036.2011.04684.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
62 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
63 Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol 2020;14:1047-59. [PMID: 32715790 DOI: 10.1080/17474124.2020.1801414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
64 Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol. 2009;31:185-205. [PMID: 19533134 DOI: 10.1007/s00281-009-0165-4] [Cited by in Crossref: 147] [Cited by in F6Publishing: 131] [Article Influence: 12.3] [Reference Citation Analysis]
65 Higuchi K, Futagami S, Yamawaki H, Murakami M, Kirita K, Agawa S, Ikeda G, Noda H, Kodaka Y, Ueki N, Kaneko K, Gudis K, Ohashi R, Iwakiri K. Endosonographic features in patients with non-alcoholic early chronic pancreatitis improved with treatment at one year follow up. J Clin Biochem Nutr 2021;68:86-94. [PMID: 33536717 DOI: 10.3164/jcbn.19-130] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-1359. [PMID: 26444549 DOI: 10.1111/eci.12548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
67 Talley NJ. What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model. Am J Gastroenterol 2020;115:41-8. [PMID: 31895721 DOI: 10.14309/ajg.0000000000000485] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
68 Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol 2009;104:1339-41. [PMID: 19491845 DOI: 10.1038/ajg.2009.295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
69 Arshi J, Layfield LJ, Esebua M. Mast cell infiltration and activation in the gallbladder wall: Implications for the pathogenesis of functional gallbladder disorder in adult patients. Ann Diagn Pathol 2021;54:151798. [PMID: 34391170 DOI: 10.1016/j.anndiagpath.2021.151798] [Reference Citation Analysis]
70 Zawahir S, Safta A, Fasano A. Pediatric celiac disease: . Current Opinion in Pediatrics 2009;21:655-60. [DOI: 10.1097/mop.0b013e32832f5b9d] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
71 Gottfried-Blackmore A, Namkoong H, Adler E, Martin B, Gubatan J, Fernandez-Becker N, Clarke JO, Idoyaga J, Nguyen L, Habtezion A. Gastric Mucosal Immune Profiling and Dysregulation in Idiopathic Gastroparesis. Clin Transl Gastroenterol 2021;12:e00349. [PMID: 33979305 DOI: 10.14309/ctg.0000000000000349] [Reference Citation Analysis]
72 McCullough R, McCullough J. Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop. Transl Gastroenterol Hepatol 2017;2:18. [PMID: 28447053 DOI: 10.21037/tgh.2017.03.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Zare-Mirzaie A, Lotfi M, Sadeghipour A, Haghi-Ashtiani MT. Analysis of colonic mucosa mast cell count in patients with chronic diarrhea. Saudi J Gastroenterol. 2012;18:322-326. [PMID: 23006460 DOI: 10.4103/1319-3767.101128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
74 Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421-431. [PMID: 21331765 DOI: 10.1007/s00535-011-0379-9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 12.1] [Reference Citation Analysis]
75 Pryor J, Burns GL, Duncanson K, Horvat JC, Walker MM, Talley NJ, Keely S. Functional Dyspepsia and Food: Immune Overlap with Food Sensitivity Disorders. Curr Gastroenterol Rep 2020;22:51. [PMID: 32797313 DOI: 10.1007/s11894-020-00789-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:363-73. [PMID: 21103418 DOI: 10.5056/jnm.2010.16.4.363] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
77 McEvoy MA, Attia JR, Oldmeadow C, Holliday E, Smith WT, Mangoni AA, Peel R, Hancock SJ, Walker MM, Talley NJ. Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case-control study. United European Gastroenterol J 2021. [PMID: 34431615 DOI: 10.1002/ueg2.12137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Kaya İslamoğlu ZG, Unal M, Küçük A. Atopic Dermatitis in Adults and Irritable Bowel Syndrome: A Cross-sectional Study. Indian J Dermatol 2019;64:355-9. [PMID: 31543528 DOI: 10.4103/ijd.IJD_490_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Halland M, Talley NJ, Jones M, Murray JA, Cameron R, Walker MM. Duodenal Pathology in Patients with Rumination Syndrome: Duodenal Eosinophilia and Increased Intraepithelial Lymphocytes. Dig Dis Sci 2019;64:832-7. [DOI: 10.1007/s10620-018-5387-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
80 Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382-391. [PMID: 24961872 DOI: 10.1111/apt.12846] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
81 Du L, Shen J, Kim JJ, He H, Chen B, Dai N. Impact of gluten consumption in patients with functional dyspepsia: A case-control study. J Gastroenterol Hepatol. 2018;33:128-133. [PMID: 28452428 DOI: 10.1111/jgh.13813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
82 Halliez MC, Motta JP, Feener TD, Guérin G, LeGoff L, François A, Colasse E, Favennec L, Gargala G, Lapointe TK, Altier C, Buret AG. Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2016;310:G574-85. [PMID: 26744469 DOI: 10.1152/ajpgi.00144.2015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
83 Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323-330. [PMID: 21552990 DOI: 10.1007/s11894-011-0197-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
84 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
85 Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9:354-75. [PMID: 27134665 DOI: 10.1177/1756283X16633050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
86 Kandulski A, Venerito M, Malfertheiner P. Therapeutic strategies for the treatment of dyspepsia. Expert Opin Pharmacother 2010;11:2517-25. [PMID: 20726822 DOI: 10.1517/14656566.2010.501794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Marlicz W, Yung DE, Skonieczna-Żydecka K, Loniewski I, van Hemert S, Loniewska B, Koulaouzidis A. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev Gastroenterol Hepatol 2017;11:961-78. [PMID: 28618973 DOI: 10.1080/17474124.2017.1343664] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
88 Gwee KA. Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia. J Neurogastroenterol Motil. 2010;16:30-34. [PMID: 20535323 DOI: 10.5056/jnm.2010.16.1.30] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
89 Tanaka F, Tominaga K, Fujikawa Y, Nagami Y, Kamata N, Yamagami H, Tanigawa T, Shiba M, Watanabe T, Fujiwara Y, Arakawa T. Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia. Dig Dis Sci 2016;61:3478-85. [PMID: 27718082 DOI: 10.1007/s10620-016-4329-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
90 Santucci NR, Hyman PE, Harmon CM, Schiavo JH, Hussain SZ. Biliary Dyskinesia in Children: A Systematic Review. J Pediatr Gastroenterol Nutr 2017;64:186-93. [PMID: 27472474 DOI: 10.1097/MPG.0000000000001357] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 6.3] [Reference Citation Analysis]
91 Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets 2020;24:511-23. [PMID: 32249629 DOI: 10.1080/14728222.2020.1752181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
92 Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010;16:251-257. [PMID: 20680163 DOI: 10.5056/jnm.2010.16.3.251] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
93 Du L, Chen B, Kim JJ, Chen X, Dai N. Micro-inflammation in functional dyspepsia: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13304. [PMID: 29392796 DOI: 10.1111/nmo.13304] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
94 Bai J, Khaldi S, Gargala G, Baishanbo A, François A, Ballet JJ, Ducrotté P, Fioramonti J, Favennec L, Le Goff L. Effects of octreotide on jejunal hypersensitivity triggered by Cryptosporidium parvum intestinal infection in an immunocompetent suckling rat model. Neurogastroenterol Motil 2011;23:1043-50, e499. [PMID: 21320238 DOI: 10.1111/j.1365-2982.2011.01680.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
95 Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract 2011;207:538-44. [PMID: 21940106 DOI: 10.1016/j.prp.2011.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
96 Lee KJ. The Usefulness of Symptom-based Subtypes of Functional Dyspepsia for Predicting Underlying Pathophysiologic Mechanisms and Choosing Appropriate Therapeutic Agents. J Neurogastroenterol Motil 2021;27:326-36. [PMID: 34210898 DOI: 10.5056/jnm21042] [Reference Citation Analysis]
97 Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil 2011;17:124-30. [PMID: 21602988 DOI: 10.5056/jnm.2011.17.2.124] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
98 Tack J, Talley NJ. Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol. 2013;10:134-141. [PMID: 23399526 DOI: 10.1038/nrgastro.2013.14] [Cited by in Crossref: 165] [Cited by in F6Publishing: 148] [Article Influence: 20.6] [Reference Citation Analysis]
99 Shanahan ER, Zhong L, Talley NJ, Morrison M, Holtmann G. Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures. Aliment Pharmacol Ther 2016;43:1186-96. [PMID: 27086880 DOI: 10.1111/apt.13622] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
100 Bryant RV, van Langenberg DR, Holtmann GJ, Andrews JM. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol 2011;26:916-23. [PMID: 21214889 DOI: 10.1111/j.1440-1746.2011.06624.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
101 Ierardi E, Losurdo G, Iannone A, Piscitelli D, Amoruso A, Barone M, Principi M, Pisani A, Di Leo A. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored? Ann Gastroenterol. 2017;30:380-392. [PMID: 28655974 DOI: 10.20524/aog.2017.0165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
102 Ford AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: Case-control study of 23471 primary care patients. Aliment Pharmacol Ther. 2014;40:827-834. [PMID: 25131320 DOI: 10.1111/apt.12903] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
103 Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:1229-1236. [PMID: 20222916 DOI: 10.1111/j.1365-2036.2010.04282.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 8.8] [Reference Citation Analysis]
104 Friesen C, Singh M, Singh V, Schurman JV. A cross-sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning. BMC Gastroenterol 2020;20:144. [PMID: 32393272 DOI: 10.1186/s12876-020-01291-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
105 Järbrink-Sehgal ME, Sparkman J, Damron A, Walker MM, Green LK, Rosen DG, Graham DY, El-Serag HE. Functional Dyspepsia and Duodenal Eosinophil Count and Degranulation: A Multiethnic US Veteran Cohort Study. Dig Dis Sci 2020. [PMID: 33185786 DOI: 10.1007/s10620-020-06689-2] [Reference Citation Analysis]
106 Talley NJ, Alexander JL, Walker MM, Jones MP, Hugerth LW, Engstrand L, Agréus L, Powell N, Andreasson A. Ileocolonic Histopathological and Microbial Alterations in the Irritable Bowel Syndrome: A Nested Community Case-Control Study. Clin Transl Gastroenterol 2020;12:e00296. [PMID: 33464728 DOI: 10.14309/ctg.0000000000000296] [Reference Citation Analysis]
107 Loktionov A. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World J Gastroenterol 2019; 25(27): 3503-3526 [PMID: 31367153 DOI: 10.3748/wjg.v25.i27.3503] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
108 Tikoo S, Barki N, Jain R, Zulkhernain NS, Buhner S, Schemann M, Weninger W. Imaging of mast cells. Immunol Rev 2018;282:58-72. [PMID: 29431206 DOI: 10.1111/imr.12631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
109 Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita ÅV, Pardon N, Santos J, Söderholm JD, Tack J, Farré R. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014;63:262-71. [PMID: 23474421 DOI: 10.1136/gutjnl-2012-303857] [Cited by in Crossref: 213] [Cited by in F6Publishing: 190] [Article Influence: 26.6] [Reference Citation Analysis]
110 Molina-infante J, Santolaria S, Montoro M, Esteve M, Fernández-bañares F. Sensibilidad al gluten no celiaca: una revisión crítica de la evidencia actual. Gastroenterología y Hepatología 2014;37:362-71. [DOI: 10.1016/j.gastrohep.2014.01.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
111 Talley NJ. Functional dyspepsia: new insights into pathogenesis and therapy. Korean J Intern Med. 2016;31:444-456. [PMID: 27048251 DOI: 10.3904/kjim.2016.091] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
112 Aro P, Talley NJ, Agréus L, Johansson SE, Bolling-Sternevald E, Storskrubb T, Ronkainen J. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33:1215-1224. [PMID: 21443537 DOI: 10.1111/j.1365-2036.2011.04640.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 10.3] [Reference Citation Analysis]
113 Taki M, Oshima T, Li M, Sei H, Tozawa K, Tomita T, Fukui H, Watari J, Miwa H. Duodenal low‐grade inflammation and expression of tight junction proteins in functional dyspepsia. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13576] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
114 Jones MP, Tack J, Van Oudenhove L, Walker MM, Holtmann G, Koloski NA, Talley NJ. Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population. Clin Gastroenterol Hepatol. 2017;15:1014-1020.e4. [PMID: 28087404 DOI: 10.1016/j.cgh.2016.12.032] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 13.3] [Reference Citation Analysis]
115 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
116 Bassotti G, Villanacci V, Creƫoiu D, Creƫoiu SM, Becheanu G. Cellular and molecular basis of chronic constipation: Taking the functional/idiopathic label out. World J Gastroenterol 2013; 19(26): 4099-4105 [PMID: 23864772 DOI: 10.3748/wjg.v19.i26.4099] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
117 Magen E, Chikovani T. Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol 2016; 22(43): 9451-9456 [PMID: 27920467 DOI: 10.3748/wjg.v22.i43.9451] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
118 Yamawaki H, Futagami S, Sakasegawa N, Murakami M, Agawa S, Ikeda G, Noda H, Kirita K, Gudis K, Higuchi K, Kodaka Y, Ueki N, Iwakiri K. Acotiamide attenuates central urocortin 2-induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF-α productions in LPS-stimulated macrophage cell lines. Neurogastroenterol Motil 2020;32:e13813. [PMID: 32030855 DOI: 10.1111/nmo.13813] [Reference Citation Analysis]
119 Shahbazkhani B, Fanaeian MM, Farahvash MJ, Aletaha N, Alborzi F, Elli L, Shahbazkhani A, Zebardast J, Rostami-Nejad M. Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial. Sci Rep 2020;10:2401. [PMID: 32051513 DOI: 10.1038/s41598-020-59532-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
120 Laing ST, Merriam D, Shock BC, Mills S, Spinner A, Reader R, Hartigan-O'Connor DJ. Idiopathic Colitis in Rhesus Macaques Is Associated With Dysbiosis, Abundant Enterochromaffin Cells and Altered T-Cell Cytokine Expression. Vet Pathol 2018;55:741-52. [PMID: 29929446 DOI: 10.1177/0300985818780449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
121 İliaz R, Akyüz F, Yeğen G, Örmeci A, Göktürk S, Akyüz Ü, Baran B, Mutluay Ö, Evirgen S, Karaca Ç, Demir K, Beşışık F, Güllüoğlu M, Kaymakoğlu S. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol 2018;29:384-91. [PMID: 30249551 DOI: 10.5152/tjg.2018.17491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Reed CC, Genta RM, Youngblood BA, Wechsler JB, Dellon ES. Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis. Clin Gastroenterol Hepatol 2021;19:2102-11. [PMID: 32801015 DOI: 10.1016/j.cgh.2020.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
123 Singh P, Leffler DA. Editorial: isolated duodenal eosinophilia-clinical condition or just seeing spots? Aliment Pharmacol Ther 2018;47:1327-8. [PMID: 29644740 DOI: 10.1111/apt.14602] [Reference Citation Analysis]
124 Suzuki H, Hibi T. Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive? J Neurogastroenterol Motil 2011;17:360-5. [PMID: 22148104 DOI: 10.5056/jnm.2011.17.4.360] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
125 Lee MJ, Jung HK, Lee KE, Mun YC, Park S. Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia. J Neurogastroenterol Motil 2019;25:212-21. [PMID: 30827070 DOI: 10.5056/jnm18176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
126 Miwa H, Oshima T, Tomita T, Fukui H, Kondo T, Yamasaki T, Watari J. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center. J Gastroenterol 2019;54:305-11. [PMID: 30767076 DOI: 10.1007/s00535-019-01550-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
127 Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012;46 Suppl:S52-S55. [PMID: 22955358 DOI: 10.1097/mcg.0b013e318264e918] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
128 Capannolo A, Necozione S, Gabrieli D, Ciccone F, Sollima L, Melchiorri L, Viscido A, Frieri G. Duodenal lymphocytosis in functional dyspepsia. Arab J Gastroenterol 2019;20:91-4. [PMID: 31175076 DOI: 10.1016/j.ajg.2019.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
129 Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1305-1318. [PMID: 27144620 DOI: 10.1053/j.gastro.2016.02.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 103] [Article Influence: 26.8] [Reference Citation Analysis]
130 Zhao W, Zhong X, Zhuang X, Ji H, Li X, Li A, Wang R, Zhu J, Li Y. Evaluation of Helicobacter pylori eradication and drug therapy in patients with functional dyspepsia. Exp Ther Med 2013;6:37-44. [PMID: 23935715 DOI: 10.3892/etm.2013.1109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Liebregts T, Adam B, Bredack C, Gururatsakul M, Pilkington KR, Brierley SM, Blackshaw LA, Gerken G, Talley NJ, Holtmann G. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol. 2011;106:1089-1098. [PMID: 21245834 DOI: 10.1038/ajg.2010.512] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
132 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 353] [Article Influence: 32.9] [Reference Citation Analysis]
133 Quigley EM, Lacy BE. Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol 2013;10:175-86. [PMID: 23296247 DOI: 10.1038/nrgastro.2012.253] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
134 Friesen CA, Schurman JV, Colombo JM, Abdel-Rahman SM. Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther 2013; 4(4): 86-96 [PMID: 24199024 DOI: 10.4292/wjgpt.v4.i4.86] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
135 Lutter L, Hoytema van Konijnenburg DP, Brand EC, Oldenburg B, van Wijk F. The elusive case of human intraepithelial T cells in gut homeostasis and inflammation. Nat Rev Gastroenterol Hepatol 2018;15:637-49. [DOI: 10.1038/s41575-018-0039-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
136 Park JK, Huh KC, Shin CM, Lee H, Yoon YH, Song KH, Min BH, Choi KD; Korean Society of Neurogastroenterology and Motility. [Current issues in functional dyspepsia]. Korean J Gastroenterol 2014;64:133-41. [PMID: 25252861 DOI: 10.4166/kjg.2014.64.3.133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
137 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
138 Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049-1057. [PMID: 25147201 DOI: 10.1136/gutjnl-2014-307843] [Cited by in Crossref: 199] [Cited by in F6Publishing: 160] [Article Influence: 28.4] [Reference Citation Analysis]
139 Guz-Mark A, Zevit N, Morgenstern S, Shamir R. Duodenal intraepithelial lymphocytosis is common in children without coeliac disease, and is not meaningfully influenced by Helicobacter pylori infection. Aliment Pharmacol Ther. 2014;39:1314-1320. [PMID: 24702235 DOI: 10.1111/apt.12739] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
140 Ekiz Ö, Balta I, Özuğuz P, Şen BB, Rifaioğlu EN, Ekiz F, Yüksel I, Coban Ş, Başar Ö. Irritable bowel syndrome in patients with chronic pruritus of undetermined origin. J Eur Acad Dermatol Venereol 2014;28:1034-9. [PMID: 24033408 DOI: 10.1111/jdv.12251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
141 Chaudhari AA, Rane SR, Jadhav MV. Histomorphological Spectrum of Duodenal Pathology in Functional Dyspepsia Patients. J Clin Diagn Res 2017;11:EC01-4. [PMID: 28764169 DOI: 10.7860/JCDR/2017/25297.9985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Afrin LB, Khoruts A. Mast Cell Activation Disease and Microbiotic Interactions. Clin Ther 2015;37:941-53. [PMID: 25773459 DOI: 10.1016/j.clinthera.2015.02.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
143 Losurdo G, Todeschini A, Giorgio F, Piscitelli D, Giangaspero A, Ierardi E, Di Leo A. Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome. Medicina (Kaunas) 2020;56:E660. [PMID: 33260434 DOI: 10.3390/medicina56120660] [Reference Citation Analysis]
144 Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010;31:326-334. [PMID: 20554042 DOI: 10.1016/j.tips.2010.04.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
145 Futagami S, Shindo T, Kawagoe T, Horie A, Shimpuku M, Gudis K, Iwakiri K, Itoh T, Sakamoto C. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol. 2010;105:1835-1842. [PMID: 20461070 DOI: 10.1038/ajg.2010.151] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 8.0] [Reference Citation Analysis]
146 Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis 2021;36:93-102. [PMID: 32879990 DOI: 10.1007/s00384-020-03727-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Kumari MV, Devanarayana NM, Amarasiri L, Rajindrajith S. Association between functional abdominal pain disorders and asthma in adolescents: A cross-sectional study. World J Clin Cases 2018; 6(15): 944-951 [PMID: 30568950 DOI: 10.12998/wjcc.v6.i15.944] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
148 Singh V, Singh M, Schurman JV, Friesen CA. Histopathological changes in the gastroduodenal mucosa of children with functional dyspepsia. Pathology - Research and Practice 2018;214:1173-8. [DOI: 10.1016/j.prp.2018.06.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
149 Jones MP, Walter S, Faresjö Å, Grodzinsky E, Kjellström L, Viktorsson L, Talley NJ, Agreus L, Andreasson A. Gastrointestinal recall questionnaires compare poorly with prospective patient diaries for gastrointestinal symptoms: data from population and primary health centre samples. European Journal of Gastroenterology & Hepatology 2019;31:163-9. [DOI: 10.1097/meg.0000000000001296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
150 Aziz I, Evans KE, Hopper AD, Smillie DM, Sanders DS. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther. 2010;32:1392-1397. [PMID: 21050242 DOI: 10.1111/j.1365-2036.2010.04477.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
151 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
152 Vanheel H, Vicario M, Boesmans W, Vanuytsel T, Salvo-Romero E, Tack J, Farré R. Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation. Sci Rep 2018;8:5383. [PMID: 29599471 DOI: 10.1038/s41598-018-23620-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
153 Walker MM, Talley NJ. The Role of Duodenal Inflammation in Functional Dyspepsia. Journal of Clinical Gastroenterology 2017;51:12-8. [DOI: 10.1097/mcg.0000000000000740] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
154 Futagami S, Itoh T, Sakamoto C. Systematic review with meta-analysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther. 2015;41:177-188. [PMID: 25348873 DOI: 10.1111/apt.13006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 11.6] [Reference Citation Analysis]
155 Tack J, Janssen P. Gastroduodenal motility. Curr Opin Gastroenterol 2010;26:647-55. [PMID: 20838344 DOI: 10.1097/MOG.0b013e32833ece1e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
156 Miura K, Oshima T, Ito C, Horikawa T, Yamada M, Tomita T, Fukui H, Miwa H. Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome. J Gastroenterol Hepatol 2021;36:951-8. [PMID: 32839988 DOI: 10.1111/jgh.15225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
157 Talley NJ. Functional Dyspepsia: Advances in Diagnosis and Therapy. Gut Liver 2017;11:349-57. [PMID: 28452210 DOI: 10.5009/gnl16055] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 16.7] [Reference Citation Analysis]
158 Duan S, Kondo T, Miwa H, Yang Y, Wang S, Kanda H, Kogure Y, Imamura N, Fujimura T, Kono T, Fukushima M, Tozawa K, Tomita T, Oshima T, Fukui H, Yamamoto S, Noguchi K, Dai Y. Eosinophil-associated microinflammation in the gastroduodenal tract contributes to gastric hypersensitivity in a rat model of early-life adversity. Am J Physiol Gastrointest Liver Physiol 2021;320:G206-16. [PMID: 33174456 DOI: 10.1152/ajpgi.00313.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155-168. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 147] [Cited by in F6Publishing: 144] [Article Influence: 24.5] [Reference Citation Analysis]